These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1442 related items for PubMed ID: 21728159

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S.
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [Abstract] [Full Text] [Related]

  • 3. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C, Lescure FX, Schmit JL, Jounieaux V.
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [Abstract] [Full Text] [Related]

  • 4. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
    Martínez Moragón E, Menéndez R, Santos M, Lorente R, Marco V.
    Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
    [Abstract] [Full Text] [Related]

  • 5. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ.
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [Abstract] [Full Text] [Related]

  • 6. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G, Ducrot R, Bourdin A, Rastogi N.
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nontuberculous mycobacterial pulmonary infections in Non-HIV patients.
    Parrish SC, Myers J, Lazarus A.
    Postgrad Med; 2008 Nov; 120(4):78-86. PubMed ID: 19020369
    [Abstract] [Full Text] [Related]

  • 9. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
    El-Solh AA, Nopper J, Abdul-Khoudoud MR, Sherif SM, Aquilina AT, Grant BJ.
    Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
    [Abstract] [Full Text] [Related]

  • 10. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K, Sano C.
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.
    Lee MR, Yang CY, Shu CC, Lin CK, Wen YF, Lee SW, Ko JC, Wang JY, Lee LN, Yu CJ.
    Clin Microbiol Infect; 2015 Mar; 21(3):250.e1-7. PubMed ID: 25658545
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 13. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society.
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [Abstract] [Full Text] [Related]

  • 14. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A.
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.
    van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D.
    Thorax; 2009 Jun; 64(6):502-6. PubMed ID: 19213773
    [Abstract] [Full Text] [Related]

  • 16. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, Izumi K, Shiraishi Y, Mitarai S, Ogata H, Kurashima A, Yoshimori K, Ohta K, Goto H, Sasaki Y.
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 2):S1-25. PubMed ID: 9279284
    [Abstract] [Full Text] [Related]

  • 18. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease.
    Chae DR, Kim YI, Kee SJ, Kim YH, Chi SY, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim SO, Kim YC, Lim SC.
    Respiration; 2011 Aug; 82(2):124-9. PubMed ID: 20926850
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary Disease Caused by Non-Tuberculous Mycobacteria.
    Wassilew N, Hoffmann H, Andrejak C, Lange C.
    Respiration; 2016 Aug; 91(5):386-402. PubMed ID: 27207809
    [Abstract] [Full Text] [Related]

  • 20. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S, Kops S, Magis-Escurra C, Boeree MJ, van Ingen J, Hoefsloot W.
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.